Abstract: Systems and methods include establishing a control channel of a tunnel utilizing a first encryption technique, wherein the tunnel is between a local node including one or more processors and a remote node, and wherein the control channel includes a session identifier; establishing a data channel of the tunnel utilizing a second encryption technique, wherein the data tunnel is bound to the control channel based on the session identifier; performing, over the control channel, device authentication and user authentication of one or more users associated with the remote node, wherein each of the one or more users includes a user identifier; and, subsequent to the device authentication and the user authentication, exchanging data packets over the data channel with each data packet including a corresponding user identifier. The first encryption technique can be one of TLS and SSL, and the second encryption technique can be one of TLS and DTLS.

Abstract: The present invention provides an improved process for the preparation of exametazime, which is used as ligand in preparation of technetium-99m complex.

Abstract: The present invention provides an improved process for the preparation of exametazime, which is used as ligand in preparation of technetium-99m complex.

Abstract: The present invention provides a novel process for the preparation of substituted optically pure (S)-(+)- or (R)-(?)-10-hydroxy-dihydrodibenz[b,f]azepines or derivatives thereof, starting from 10,11-dihydro-10-oxo-5H-dibenz[b,f]azepines using boronate esters or their derivatives. The present invention also provides use of thus prepared (S)-(+)- or (R)-(?)-10-hydroxy-dihydrodibenz[b,f]azepines for the preparation of their ester such as (S)-(?)-10-acetoxy-10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide or (R)-(+)-10-acetoxy-10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide. The present invention also provides novel solid state crystalline forms J1, J2, J3, J4 and amorphous form of eslicarbazepine and the process for the preparation thereof. Also, the present invention provides novel solid state crystalline form and amorphous form of eslicarbazepine acetate and the process for the preparation thereof.

Abstract: The present invention provides a novel process and novel intermediates useful in the synthesis of pharmaceutically active compounds, especially renin inhibitors, such as Aliskiren, or a salt thereof, preferably Aliskiren hemifumarate.

Abstract: The present invention provides a novel process and novel intermediates useful in the synthesis of pharmaceutically active compounds, especially renin inhibitors, such as Aliskiren, or a salt thereof, preferably Aliskiren hemifumarate.

Abstract: The present invention provides a novel process for the preparation of substituted optically pure (S)-(+)- or (R)-(?)-10-hydroxy-dihydrodibenz[b,f]azepines or derivatives thereof, starting from 10,11-dihydro-10-oxo-5H-dibenz[b,f]azepines using boronate esters or their derivatives. The present invention also provides use of thus prepared (S)-(+)- or (R)-(?)-10-hydroxy-dihydrodibenz[b,f]azepines for the preparation of their ester such as (S)-(?)-10-acetoxy-10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide or (R)-(+)-10-acetoxy-10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide. The present invention also provides novel solid state crystalline forms J1, J2, J3, J4 and amorphous form of eslicarbazepine and the process for the preparation thereof. Also, the present invention provides novel solid state crystalline form and amorphous form of eslicarbazepine acetate and the process for the preparation thereof.

Abstract: Disclosed herein are novel intermediates and process for large scale production of (S)-3-[(1-dimethylamino)ethyl]phenyl-N-ethyl-N-methyl-carbamate (rivastigmine) or its pharmaceutically acceptable salts employing the novel intermediates. Further provided are methods for producing the novel intermediates thereof.

Abstract: A method, a system and a computer program product for providing status metric of a project to a user is a provided. An input data corresponding to the project may be received from a service provider. Further, the input data may be validated based on one or more pre-defined rules. The validated data may be aggregated into one or more tables. One or more attributes of the aggregated data, from the one or more tables, may be analyzed to generate one or more reports. The generated report includes project information corresponding to the project. Further, the generated reports may be provided to the user. Thereby, the method provides the status metric of the project to the user.

Abstract: In accordance with one embodiment of present disclosure, a system and a method for creating business intelligence dashboard mockups are provided. The system includes a questioning module, a dashboard generating module and a display module. The questioning module is capable of receiving an input data, from a user. The dashboard generating module includes a data source and a dashboard generating module that includes a data generator module. The data generator module is configured to calculate one or more random measures by analyzing one or more values from the input data. Further, the data generator module is configured to generate one or more reports based on the one or more random measures and the input data. Further, the display module is configured for enabling the user to view the one or more reports. Furthermore, the system facilitates the user to modify the data source to modify the reports.

Abstract: Disclosed herein are novel intermediates and process for large scale production of (S)-3-[(1-dimethylamino)ethyl]phenyl-N-ethyl-N-methyl-carbamate (rivastigmine) or its pharmaceutically acceptable salts employing the novel intermediates. Further provided are methods for producing the novel intermediates thereof.

Abstract: In accordance with an aspect of the present invention, a corresponding list of muxes is maintained for each combination of a peripheral and a mux option. The list is then retrieved to program the required muxes to connect the communication paths from a peripheral on the corresponding mux option, based on which the list is retrieved. In an embodiment, the information is maintained in the form of a table, with each entry storing the data corresponding to a mux and mux option. The entries are linked by appropriate pointers to form the linked list.

Abstract: Graphical business intelligence tool. An example of a method for providing graphical business intelligence (BI) tool with a touch screen user interface includes receiving user authentication information and displaying one or more briefing books. The method includes displaying one or more chapters associated with the one or more briefing books. The method includes displaying maps, images and layouts associated to the one or more chapters. The method includes presenting Business Intelligence reports that take input from the maps, the images and, the layouts. The method includes allowing the one or more briefing books, chapters, measures, features, BI Reports to be configured. The method also includes creating graphical representations of dimensions used by a vertical, enabling graphical navigation capabilities in the graphical BI tool, calibrating the touch screen user interface with the graphical BI tool, and deploying the graphical BI tool with the touch screen user interface.

Abstract: In accordance with an aspect of the present invention, a corresponding list of muxes is maintained for each combination of a peripheral and a mux option. The list is then retrieved to program the required muxes to connect the communication paths from a peripheral on the corresponding mux option, based on which the list is retrieved. In an embodiment, the information is maintained in the form of a table, with each entry storing the data corresponding to a mux and mux option. The entries are linked by appropriate pointers to form the linked list.